These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32030886)

  • 1. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
    Yang Y; Song S; Meng Q; Wang L; Li X; Xie S; Chen Y; Jiang X; Wang C; Lu Y; Xin X; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
    J Cell Mol Med; 2020 Mar; 24(5):2772-2790. PubMed ID: 32030886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
    An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
    Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
    Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
    Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
    Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
    Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
    Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
    Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
    Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
    Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
    Cai M; Chen Q; Shen J; Lv C; Cai L
    J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
    Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
    Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.
    Cloos PA; Christensen J; Agger K; Maiolica A; Rappsilber J; Antal T; Hansen KH; Helin K
    Nature; 2006 Jul; 442(7100):307-11. PubMed ID: 16732293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
    Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
    Zippo A; De Robertis A; Serafini R; Oliviero S
    Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-tuning AKT kinase activity through direct lysine methylation.
    Guo J; Wei W
    Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
    Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
    Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
    Cai L; Ma X; Huang Y; Zou Y; Chen X
    Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
    Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
    Exp Mol Pathol; 2015 Dec; 99(3):399-408. PubMed ID: 26341139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.